Literature DB >> 21785958

Urticaria and dermographism in patients with adult-onset Still's disease.

Paulo Ricardo Criado1, Jozélio Freire de Carvalho, Liliane Akemi Ayabe, Hebert Roberto Clivati Brandt, Ricardo Romiti, Celina W Maruta.   

Abstract

Adult-onset Still's disease (AOSD) patients typically present with arthralgia, fever, lymphadenopathy and a transient salmon maculopapular rash. Only approximately 25 cases of AOSD with urticaria were described in the literature. In this article, the authors report three additional cases of AOSD with urticarial and dermographic lesions who had a good clinical response to glucocorticoid and antihistamines. A review of the literature concerning this issue is also herein written.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785958     DOI: 10.1007/s00296-011-2025-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Urticaria as a presenting manifestation of adult-onset Still's disease.

Authors:  F Salaffi; G Filosa; L Bugatti; M D Maestrini
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

2.  A case of adult-onset Still's disease presenting with angioedema.

Authors:  Mehmet Soy
Journal:  Clin Rheumatol       Date:  2003-12-18       Impact factor: 2.980

3.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

4.  Adult-onset Still's disease: an uncommon differential diagnosis of urticaria and treatment with anakinra.

Authors:  A Gesierich; J Stoevesandt; C Kneitz; E-B Bröcker; M P Schön
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-01       Impact factor: 6.166

5.  Still's disease in the adult.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

6.  Urticaria as a cutaneous sign of adult-onset Still's disease.

Authors:  Roberta F J Criado; Paulo Ricardo Criado; Cidia Vasconcellos; José Carlos M Szajubok; Nilceo S Michalany; Bogdana Victoria Kadunc; Jose Eduardo Costa Martins
Journal:  J Cutan Med Surg       Date:  2006 Mar-Apr       Impact factor: 2.092

Review 7.  Persistent plaques and linear pigmentation in adult-onset Still's disease.

Authors:  K Suzuki; Y Kimura; M Aoki; S Takezaki; T Tuchida; T Takano; S Kawana
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

8.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

Review 9.  Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature.

Authors:  Carine Kieffer; Bernard Cribier; Dan Lipsker
Journal:  Medicine (Baltimore)       Date:  2009-01       Impact factor: 1.889

10.  Ten years of clinical experience with adult onset Still's disease: is the outcome improving?

Authors:  Sukhbir Singh Uppal; Moudhi Al-Mutairi; Sawsan Hayat; Mini Abraham; Anand Malaviya
Journal:  Clin Rheumatol       Date:  2006-11-04       Impact factor: 3.650

View more
  12 in total

1.  Refractory urticaria in adult-onset Still's disease.

Authors:  Han-Chi Tseng; Chih-Hung Lee
Journal:  Rheumatol Int       Date:  2014-02-05       Impact factor: 2.631

2.  Cutaneous manifestations associated with adult-onset Still's disease: important diagnostic values.

Authors:  Toshiyuki Yamamoto
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

3.  Oral mucosa lesions as atypical manifestation of adult-onset Still´s disease.

Authors:  María Lorena Brance; Eldo Luis Neffen
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

Review 4.  Cutaneous manifestations of adult-onset Still's disease: a case report and review of literature.

Authors:  Alessandra Cozzi; Anastasia Papagrigoraki; Domenico Biasi; Chiara Colato; Giampiero Girolomoni
Journal:  Clin Rheumatol       Date:  2014-04-17       Impact factor: 2.980

5.  Typical evanescent and atypical persistent polymorphic cutaneous rash in an adult Brazilian with Still's disease: a case report and review of the literature.

Authors:  Despina Michailidou; Junghee Shin; Inga Forde; Kavitha Gopalratnam; Paul Cohen; Angela DeGirolamo
Journal:  Auto Immun Highlights       Date:  2015-09-30

6.  Adult-onset Still's disease with atypical cutaneous manifestations.

Authors:  Francisco Javier Narváez Garcia; María Pascual; Mercè López de Recalde; Pablo Juarez; Isabel Morales-Ivorra; Jaime Notario; Anna Jucglà; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Diagnostic Challenge: A Report of Two Adult-Onset Still's Disease Cases.

Authors:  Sakunee Niranvichaiya; Daranporn Triwongwaranat
Journal:  Case Rep Dermatol Med       Date:  2017-09-25

Review 8.  Maculopapular skin eruptions associated with Covid-19: A systematic review.

Authors:  Saad Shams; Sawai Singh Rathore; Priyanka Anvekar; Manush Sondhi; Neeraj Kancherla; Sohaib Tousif; Gianpier Alonzo Rojas; Noman Khurshid Ahmed; Mehwish Munawwar; Muhammad Noman
Journal:  Dermatol Ther       Date:  2021-02-02       Impact factor: 3.858

Review 9.  Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.

Authors:  Paulo Ricardo Criado; Beatrice Martinez Zugaib Abdalla; Isabelle Carvalho de Assis; Cristina van Blarcum de Graaff Mello; Gabriela Cacciolari Caputo; Ingrid Campos Vieira
Journal:  Inflamm Res       Date:  2020-06-02       Impact factor: 6.986

Review 10.  Lessons from dermatology about inflammatory responses in Covid-19.

Authors:  Paulo Ricardo Criado; Carla Pagliari; Francisca Regina Oliveira Carneiro; Juarez Antonio Simões Quaresma
Journal:  Rev Med Virol       Date:  2020-07-12       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.